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In the last two decades, the view on the function of ceramide as a sole metabolic precursor for other sphingolipids has completely
changed. A plethora of studies has shown that ceramide is an important lipid cell-signaling factor regulating apoptosis in a variety
of cell types. With the advent of new stem cell technologies and knockout mice for speciﬁc steps in ceramide biosynthesis, this
view is about to change again. Recent studies suggest that ceramide is a critical cell-signaling factor for stem cell diﬀerentiation
and cell polarity, two processes at the core of embryo development. This paper discusses studies on ceramide using in vitro
diﬀerentiated stem cells, embryo cultures, and knockout mice with the goal of linking speciﬁc developmental stages to exciting
and novel functions of this lipid. Particular attention is devoted to the concept of ceramide as a topological cell-signaling lipid: a
lipid that forms distinct structures (membrane domains and vesicles termed “sphingosome”), which conﬁnes ceramide-induced
cell signaling pathways to localized and even polarized compartments.
1. Ceramide: Taming of the Sphinx
When the “father of neurochemistry”, the German pathol-
ogist Johann Ludwig Wilhelm Thudichum (1829–1901),
coined the term sphingolipids at the end of the 19th
century, he must have thought of the Sphinx, a mythological
creature testing human wit by asking riddles (which ended
deadly if not answered correctly). Indeed, deﬁning the
cell-signaling function of the sphingolipid ceramide is like
trying to solve a riddle posed by the Sphinx (without
the grim ending, hopefully). The discovery that ceramide
has a cell-signaling function goes back by more than 20
years. Interestingly, the ﬁrst studies on ceramide elevation
by serum deprivation or vitamin D incubation rather
focused on the role of ceramide in cell cycle arrest and
diﬀerentiation [1–3]. It was a few years later that ceramide
emerged as one of the key factors inducing apoptosis
[4–6].
Since then, several thousand publications have focused
on ceramide-inducing apoptosis, while much fewer studies
were concerned with other functions of ceramide. This was
mainly due to the limited availability of genetic approaches
to alter ceramide metabolism and the rather broad group
speciﬁcity of ceramide analogs and biosynthesis inhibitors.
In particular, studies in Dr. Alfred Merrill’s laboratory
have shown that although inhibitors such as myriocin
(serine palmitoyl transferase) and fumonisin B1 (ceramide
synthases)arespeciﬁcfortheirtargetenzymes,theinhibitory
eﬀect leads to the depletion of many ceramide species and
derivatives [7–12]. Moreover, inhibiting ceramide synthase
with fumonisin B1 can also result in the elevation of
sphingosine (dihydrosphingosine), which itself can be toxic
for various cell types. Therefore, loss-of-function experi-
ments using these inhibitors do not accurately pinpoint
which sphingolipid is instrumental in apoptosis (or other
biological eﬀects). On the other hand, gain-of-function2 Journal of Lipids
experiments using ceramide analogs are troubled by the
low water solubility of compounds whose structure comes
close to that of natural ceramide (C16–C24 ceramide). In
addition, water-soluble short-chain ceramides such as C6
o rC 8c e r a m i d ec a nb er e c y c l e da n dc o n v e r t e dt ol o n g
chain ceramides [13–15]. Therefore, biological eﬀects lost
or regained could have been attributed to various ceramide
speciesandderivatives.However,aparticularcombinationof
ceramide biosynthesis/metabolism inhibitors and ceramide
or ceramide analogs successfully demonstrated the cell-
signaling function of ceramide. When cells are preincubated
with the ceramide synthase inhibitor fumonisin B1, addition
of distinct ceramide species or ceramide analogs can restore
the ceramide-related phenotype. Because de novo biosyn-
thesis as well as the recycling pathway is inhibited, exoge-
nously added ceramide is not converted to other ceramide
species (although degradation and conversion to ceramide
derivatives is still possible). Exceptionally powerful is the
combination of myriocin or fumonisin B1 with ceramide
analogsthatarenotconvertibletoothersphingolipids. Using
this combination of reagents, our laboratory has shown for
the ﬁrst time that speciﬁc ceramide species are vital for
the formation and diﬀerentiation of embryonic epithelia
[16, 17].
2. DifferentiatingStem Cells and
the Bright Side of Ceramide
Embryonic stem (ES) cells in vitro diﬀerentiated to neural
cell types undergo phenotypical changes that recapitulate
embryo development. In the ﬁrst diﬀerentiation step called
germ layer formation, nonpolarized stem cells form embry-
oid bodies that are composed of a two-layer sphere: an
outer primitive endoderm and an inner primitive ectoderm
layer [16]. Since the primitive ectoderm is the primordial
epithelium for all embryonic tissues, embryoid bodies are
ab o n aﬁ d ein vitro model for the acquisition of germ layer
cell polarity. Apicobasal cell polarity of primitive ectoderm
cells is crucial for the organization and morphogenesis of
the three embryonic germ layers: endoderm, mesoderm,
and ectoderm. When embryoid bodies were depleted of
ceramide by the incubation with myriocin or fumonisin
B1, they did not form a primitive ectoderm layer. Instead,
massive apoptosis of cells within the embryoid bodies was
observed [16]. Supplementation of the culture medium with
C16 ceramide or the novel ceramide analog N-oleoyl serinol
(S18) prevented apoptosis and restored primitive ectoderm
formation (Figure 1 for structures). These intriguing results
were the ﬁrst experimental evidence that ceramide was
functionally involved in the regulation of embryonic cell
polarity.
S18 is a special kind of ceramide analog designed and
synthesized in our laboratory [18, 19]. By maintaining
the polar (serine-derived) head group of ceramide, and
at the same time, enhancing the water solubility of the
lipophilic portion, we obtained a water-soluble, but still
lipophilic, structural analog of ceramide (Figure 1). The
extensive characterization of S18 showed that it incorporates
into cell membranes and activates atypical PKC (aPKC),
which was also found for ceramide [18–21]. Moreover,
ceramide and S18 induce the formation of aPKC-associated
complexes with polarity proteins such as Par6 and the
small Rho-type GTPase Cdc42 (Figures 2(a) and 2(b)).
This was shown using in vitro complementation assays with
ceramide vesicles and puriﬁed proteins, but also in living
cells visualizing S18-induced polarity protein complexes by
immunocytochemistry [16, 17, 20–22]. Most excitingly, by
developing a highly speciﬁc antibody against ceramide, we
could show that the S18-induced protein complexes were
identical to those associated with ceramide [16, 17, 23].
Therefore, our studies explained for the ﬁrst time how
ceramide can organize cell polarity on the molecular level.
Primitive ectoderm cells encompassing the lumen of the
embryoid body are polarized similar to cells in the primitive
ectoderm layer of the preimplantation embryo. The apical
cellmembranefacingthelumenorthepro-amnioticcavityis
associated with F-actin and interconnected to adjacent cells
via β-catenin. Using the anticeramide antibody, we found
that in primitive ectoderm cells of embryoid bodies, the
apical membrane was tremendously enriched in ceramide
and codistributed with aPKC, Cdc42, F-actin, and β-catenin
[16]. The apical membrane of the preimplantation embryo
was also enriched in ceramide and codistributed with F-
actin. Taken together, these results led us to design a model
for ceramide-induced cell polarity. In this model, apical
ceramiderecruitsaPKCtothemembraneandorganizesacell
polarity complex with Par6 and Cdc42, thereby stabilizing β-
catenin and F-actin [22]. This was the ﬁrst model combining
the topological/structural properties of ceramide with a cell-
signaling pathway regulating cell polarity (Figure 2(b)).
Cell polarity complexes associated with aPKC are not
only involved in the acquisition of apicobasal polarity, but
also in other cell-polarity-related processes such as cell
adhesion and migration. Therefore, we tested if the function
of ceramide can be extended to other aspects of aPKC-
controlledcellpolarity.Sofar,wehavefoundthatceramideis
critical for cell migration of neural progenitors, cell adhesion
of epithelia, and ciliogenesis [16, 21, 22, 24]. The function of
ceramide in these processes will be discussed in the following
sections.
3.Cellson the Rest GettingReady toMove:
New Par-Tners Court for Ceramide
From the very beginning, ceramide was found to be
elevated in resting cells. As a typical response to serum
deprivation/withdrawal, cells go into G0 cell cycle arrest
concurrent with hydrolysis of sphingomyelin to ceramide [1,
3]. Recently, it has been shown that the elevation of ceramide
in serum-deprived cells activates protein phosphatase 2a
(PP2a) which then activates histone deacetylase (HDAC)
and downregulates telomerase, an enzyme critical for cell
cycle progression [25]. Our laboratory was interested in
ﬁnding out which other properties of nonproliferating cells
are regulated by ceramide. Madin Darby Canine Kidney
(MDCK) cells are an exquisite in vitro model to study
the dynamics of cell adhesion, polarity, and ciliogenesis inJournal of Lipids 3
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Figure 1: Structure of ceramide and its derivatives. (a) Natural derivatives of ceramide. All of the sphingolipids are derived from the
condensation reaction of serinewith palmitoyl-CoA,which is followed byreduction,acylation, anddesaturationreactionstoyieldceramide.
In addition to the derivatives shown, glucosyl- or galactosylceramide and ceramide-1-phosphate are important structural and cell-signaling
lipids, in particular for myelin formation and inﬂammation. (b) Synthetic analog of ceramide. The polar serine head group is preserved in
ceramide and many sphingolipid analogs (only one analog (S18) is shown here). This minimal structural motif is composed of two hydroxyl
groups β-positioned to an amino group or an imino group, which is linked to a hydrocarbon chain (dashed box, S18 or N-oleyl serinol is a
derivative of 2-amino 1,3-propanediol).
resting cells. MDCK cells are rapidly dividing until they
reach conﬂuence. They establish ﬁrm adhesion junctions
and eventually develop a primary cilium. This cilium only
appears in G0-arrested cells and disappears when cells re-
enter the cell cycle. Therefore, we used conﬂuent and serum-
deprived MDCK cells to study the function of ceramide in
cell adhesion and ciliogenesis. Based on our results with
embryonic epithelia, we focused on the eﬀect of ceramide on
aPKC, a key factor in the assembly of polarity complexes that
are critical for cell adhesion and ciliogenesis.4 Journal of Lipids
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Figure 2: Structure of aPKC and the “ﬂipside” model of ceramide activity. (a) In aPKC (Figure shows PKCζ), the N-terminal (regulatory)
and C-terminal (catalytic) moieties are connected by a hinge region. The N-terminus contains a pseudosubstrate (PS) motif and a PB1
domain. The PB1 domain is associated with the polarity protein Par6 that itself binds to Cdc42. The hinge region contains a C1b domain
that has been suggested to be associated with ceramide and is a putative binding site for PAR-4. The C-terminal moiety contains the catalytic
domain and several phosphorylation sites involved in activation of the enzyme. Most recently, we have constructed a dominant negative
mutant from the C-terminus of aPKC (C20ζ-GFP) that binds to ceramide. Therefore, aPKC may contain two distinct ceramide-binding
sites. In the inactive state of aPKC, the N-terminal PS motif “folds back” onto the C-terminal catalytic domain and blocks its access to
protein substrates. We have proposed that binding to ceramide “opens up” aPKC and primes its activation by phosphorylation or inhibition
by PAR-4 (Flipside model of ceramide activity). (b) For the activation reaction, ceramide binding to aPKC is followed by its association with
Par6 and Cdc42. PIP2 or 3 may participate in aPKC activation and subcellular translocation by binding to active (GTP-associated) Cdc42 in
this complex. This ceramide-aPKC polarity complex (CAP-PC) may inhibit GSK-3β and control cell polarity, process formation/migration,
or ciliogenesis as described in Figure 3. In the presence of increased levels of active PAR-4, ceramide-associated aPKC binds to PAR-4 and
formsaceramide-aPKCapoptosiscomplex(CAP-AC).ThiscomplexinhibitsaPKCandpreventsactivationofitsdownstreamtargets,NF-κB
and Akt. We have proposed that this leads to activation of Bax/Bad and induction of apoptosis.
The role of ceramide binding to aPKC was determined
by ﬁrst generating a dominant negative mutant of aPKC
(C20ζ-GFP), which binds ceramide but does not associate
withorphosphorylateclientproteinsinvolvedincellpolarity
[22]( Figure 2(a)). Based on the results of binding assays
using proteolytic fragments of aPKC, we narrowed down
the ceramide binding site to amino acid 405–592 in the
C-terminal moiety of the enzyme. This portion of aPKC
does not bind to the polarity protein Par6 and does not
encompass the kinase domain. Binding of ceramide to the C-
terminus of aPKC was very surprising since the C1 domain
(amino acid 131–180) in the regulatory portion of the
enzyme was previously suggested to bind to ceramide [26,
27]( Figure 2(a)). Most recently, the C1 domain of a related
protein has been found to bind to ceramide [28]. Therefore,
it is likely that aPKC has two ceramide-binding sites, one
in the C1 domain and another one in the C-terminus.
However, based on our results, we conclude that binding
to the C-terminal portion was suﬃcient to compete with
endogenous aPKC for ceramide. We tested the eﬀect of the
dominant negative mutant using immunocytochemistry for
adherensjunctionproteinsandbymonitoringtransepithelial
resistance [21]. Expression of the dominant-negative mutant
in conﬂuent MDCK cells compromised adherens junctionsJournal of Lipids 5
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Figure 3: A core complex associated with ceramide may regulate cell polarity. (a) Ceramide microdomains or rafts may be formed after
local hydrolysis of sphingomyelin catalyzed by acid or neutral sphingomyelinase. PIP2 or 3 embedded in these ceramide microdomains
may bind to Cdc42 (via PH domain), while ceramide-associated aPKC binds to Par6. The formation of a SphingoLipid (here ceramide)-
Induced Protein Scaﬀold (SLIPS) then regulates the dynamics of the cytoskeleton via additional proteins such as GSK-3β. This may sustain
ceramide-rich platforms (e.g., in the apical membrane of primitive ectoderm cells) or initiate processes (“sphingopodia”) in neural stem
and progenitor cells. The image on the right panel shows staining of ceramide microdomains using a ceramide-speciﬁc antibody generated
in our laboratory. Note that the plus end of microtubules appears to attach to the ceramide domains. (b) Likewise, we have found that a
pericentriolar, apical ceramide-enriched compartment (ACEC) appears to be attached to the basal body of the primary cilium. The right
panel shows the ring-shaped structure of this compartment that we have termed “sphingosome”. (c) We hypothesize that a ceramide-aPKC
polarity complex (CAP-PC) consisting of ceramide, aPKC, Par6, Cdc42, and Par3 forms a functional key element of many cell polarity-
relatedprocessesincludingcelladhesion,processformation(“sphingopodia”),cellmigration,andciliogenesis.Thelocalassemblyofdistinct
sphingolipid-induced protein scaﬀolds (SLIPs) determines the functional speciﬁcity of this polarity complex.6 Journal of Lipids
and epithelial cell contacts by aﬀecting the intracellular
distribution and protein levels of E-cadherin and β-catenin.
The two proteins were no longer distributed to the adherens
junctions, where they participate in a larger protein complex
withaPKC.Sincethisadherensjunctioncomplexisregulated
by the association of aPKC with Par6 and Cdc42, it is
likely that the dominant negative mutant competed with
endogenous aPKC for binding to ceramide, but it was not
associated with other proteins required to form the junction
complex. Consistently, depleting MDCK cells of ceramide
with fumonisin B1 also impaired transepithelial resistance,
which was restored by the addition of S18 or C16 ceramide
[21]. Based on these results, it is reasonable to hypothesize
thattheceramide-aPKCinteractionisavitalpartoftheentry
reaction in the formation of adherens junctions in epithelial
cells.
In the ventricular neuroepithelium of mouse embryonic
brain, neural progenitors divide asymmetrically with one
daughter cell staying attached to the epithelium, while the
other daughter cell migrates toward the cortical layer and
eventually undergoes neural diﬀerentiation. Interestingly,
aPKC is critical for two apparently opposite processes related
to cell polarity: cell adhesion of neural progenitors in the
neuroepithelium and migration of neural progenitors away
from it. We tested if the ceramide-aPKC interaction was
also important for these cell-polarity-related processes in the
neuroepithelium. A reliable in vitro assay to test the eﬀect of
a compound on motility and migration is the wounding or
scratch migration assay. Cells will be grown to conﬂuence,
a gap prepared by scraping oﬀ cells, and the velocity will be
determined by which cells migrate into the gap. Our results
showed that depleting neural progenitors of ceramide using
myriocin signiﬁcantly slowed down cell migration [17].
Migration was restored by supplementing the medium with
S18 or C16 and C18:1 ceramide. We used C18:1 ceramide
because it was one of the major ceramide species found
in neural progenitors (in contrast to C18 ceramide, the
monounsaturated C18:1 ceramide is a minor species in adult
brain [29]). The typical short-chain ceramide analogs used
for induction of apoptosis such as C2 or C8 ceramide did
not induce or restore migration. This was the ﬁrst evidence
that distinct ceramide species are required for aPKC-related
cell polarity. In conjunction with the previous results on api-
cobasalpolarity of primitive ectoderm cells and celladhesion
ofMDCKcells,onemayspeculatethatC16ceramideismore
importantforpolarityandadhesionofnonmotilecells,while
C18:1 ceramide is more involved in cell migration.
With the advent of knockout mice for speciﬁc ceramide
synthases, the focus of the ceramide ﬁeld has switched
from the more generalized eﬀect of ceramide depletion or
supplementation to a distinct ceramide composition. In this
regard, the ceramide synthase 2 (CerS2 or lass2) knockout
mouse shows a remarkable phenotype. Knockout of CerS2
results in hepatocarcinomas and myelin defects eventually
leading to death of mice within two years after birth [30–
32]. The complete depletion of very long-chain ceramides
(C22 and C24 ceramide) in liver and brain is consistent
with the substrate speciﬁcity of CerS2 for the respective acyl
CoA. However, the total ceramide levels are not diﬀerent
from those of the wild type because loss of very long-chain
ceramides is compensated by the elevation of C16 and C20
ceramide. Moreover, CerS2 knockout mice also show ele-
vation of phospholipids such as phosphatidylethanolamine
with C18:1 and C18:2 fatty acids [31]. The authors of the
CerS2 knockout study found that these changes increase
the membrane ﬂuidity, which was due to the compensatory
changes in the lipid composition of the mouse. It should be
mentioned that these mice are devoid of C24:1 ceramide,
a very long-chain ceramide that is a major species in the
cell membrane and known to increase membrane ﬂuidity
because of its nonsaturation. With respect to migration of
neural progenitors, it is reasonable to speculate that the
exquisite properties of C18:1 ceramide to enhance migration
may be due to similar eﬀects on membrane ﬂuidity. It is
noteworthy that similar eﬀects of nonsaturated ceramide on
enhancing membrane ﬂuidity have also been shown for cold
adaptation of plants, suggesting that membrane ﬂuidity is a
parameter critically regulated by ceramide in a vast variety
of organisms [33]. It will be part of our future research to
determine if speciﬁc changes in the ceramide composition
of the cell membrane are correlated with distinct functions
during neural progenitor diﬀerentiation.
4.A po pt o sisasP o l arityDiso r d e r:
When AtypicalPARtnersAkt upon Bad
While the previous sections were focused on the beneﬁcial
rolesofceramideincelladhesionandmigration,cellpolarity
of neural progenitors may also be disturbed by proapoptotic
proteins competing with polarity proteins for binding to
ceramide-associated aPKC. Apoptosis of neural progenitors
may thus be a polarity disorder on the cellular and molecular
level. We found that prostate apoptosis response 4 (PAR-4,
not related to Par6), a pro-apoptotic protein ﬁrst described
in prostate cancer cells, sensitizes neural progenitors to
ceramide-induced apoptosis [20, 22, 34–38]. Using in vitro
complementation assays with ceramide vesicles, coimmuno-
precipitation assays, and immunocytochemistry using an
antibody against ceramide developed in our laboratory, we
found for the ﬁrst time that ceramide induces binding of
aPKCtoPAR-4[20,23,35,36].Thiswasconsistentwithsim-
ilar ﬁndings in other cell types showing that binding of PAR-
4 inhibits aPKC [39, 40]. In conjunction with our studies on
ceramide-inducedassociationof Par6-Cdc42withaPKC,itis
reasonable to speculate that PAR-4 and Par6-Cdc42 compete
for binding to ceramide-associated aPKC (Figure 2(b)).
In cells with low PAR-4 expression (or inactive PAR-
4), ceramide-associated aPKC nucleates a polarity protein
complex by binding to Par6 and Cdc42. This will either
stabilize cell adhesion (via E-cadherin and β-catenin) or
induce migration (via inactivation of GSK-3β;s e e[ 17, 21]
for details) (Figure 2(b)). The regulation of the balance
between cell adhesion and migration involving a similar
aPKC-associated protein complex is still enigmatic. It may
very well be controlled by binding of aPKC to membrane
lipids such as distinct ceramide or phosphatidylinositol
phosphate (PIP) species, which recruit and stabilize diﬀerent
protein scaﬀolds associated with aPKC (Figure 3(a))[ 22].Journal of Lipids 7
On the other hand, if PAR-4 expression is high (or PAR-4
is activated), the ceramide-aPKC lipid-protein complex will
be inhibited by PAR-4 (Figure 2(b)).
In diﬀerentiating ES cells, we have found that this
mechanism can eliminate unwanted tumorigenic stem cells.
When embryoid bodies are plated on tissue culture dishes,
the attached cells undergo neural diﬀerentiation in the
absenceofserumandthepresenceofﬁbroblastgrowthfactor
2 (FGF-2). Interestingly, there is an enormous rate of cell
deathintheﬁrst48hofcultivationdiminishing abouthalfof
the culture. The apoptotic cells show high expression level of
Oct-4, a marker for pluripotency typical for primitive ecto-
derm cells, and PAR-4, the sensitizer for ceramide-inducible
apoptosis [34, 35, 37]. We conﬁrmed the critical role of
PAR-4 for apoptosis by knocking-down this protein, which
resulted in survival of the Oct-4-expressing cells. Moreover,
supplementation of the medium with the ceramide analog
S18 eliminated Oct-4/PAR-4 coexpressing stem cells [37].
This result was very exciting and signiﬁcant because stem
cells that retain Oct-4 expression formed tumors (teratoma)
instead of diﬀerentiating and integrating into the host tissue.
Elimination of these tumor stem cells by S18 is a major step
in enhancing the safety of stem cell transplantation.
It should be noted that another group has followed
up on our studies by administering liposomal ceramide to
undiﬀerentiated human ES cells [41]. This group found
that ceramide can maintain the undiﬀerentiated state
by eliminating prematurely diﬀerentiated cells. On ﬁrst
sight, this may be contradictory to our results in that we
reported the elimination of residual pluripotent stem cells
by ceramide. However, residual pluripotent stem cells are
not identical to undiﬀerentiated cells because they are
derived from primitive ectoderm in embryoid bodies. These
cells are, similar to prematurely diﬀerentiated stem cells,
dysfunctional in that they deviate from the normal path of
diﬀerentiation. We have termed these cells “Zombie cells”
because they remain “undead” and form tumors unless
they are eliminated by the administration of ceramide
analogs [37]. It should also be noted that the precise role of
ceramide in stem cell diﬀerentiation is still unclear. While
our studies and those from other laboratories show that
ceramide eliminates improperly diﬀerentiating stem cells,
recent work suggests that ceramide may also induce stem cell
diﬀerentiation [35, 41–43]. As a cautionary note, however,
one should distinguish between the eﬀect of endogenous
and exogenously added ceramide, in particular when using
short-chain ceramide such as C2 ceramide. A comprehensive
analysis of endogenous ceramide species during stem cell
diﬀerentiation has shown that consistent with vast changes
in the expression of diﬀerent ceramide synthase isoforms,
the proportion of C18, C24, and C24:1 ceramide increases
while that of C16 ceramide decreases when undiﬀerentiated
E Sc e l l sm a t u r et oe m b r y o i db o d i e s[ 44].
Despite this translational outcome of our work showing
a method to eliminate tumor stem cells via PAR-4 as a
sensitizer to ceramide analogs, the physiological function
of PAR-4 for neural development still remains unclear. At
ﬁrst, we were intrigued by the observation that PAR-4 is
asymmetricallydistributedduringcelldivisionofneuralpro-
genitors. We found that the PAR-4 inheriting (or expressing)
daughter cell died, while the PAR-4 (-), nestin expressing
daughter cell, survived and underwent further neuronal
diﬀerentiation [35]. We thought that this would be a great
way to eliminate half of the neural progenitor population as
observed during mouse brain development. However, since
the PAR-4 knockout mouse did not show a gross embryonic
phenotype, we focused on PAR-4 as a protein that induces
apoptosis if inappropriately expressed during embryonic
or postnatal development. We found that the pathological
expression of PAR-4 facilitates ceramide-induced apoptosis
in two cell types: neural crest-derived cells and astrocytes.
Neural crest-derived cells are the precursors for many
neuralandnonneuralcelltypes.Theyoriginatefromtheroof
plate of the closing neural tube (neural crest) and proliferate
and migrate extensively throughout the embryo. Among
the tissues diﬀerentiated from neural crest-derived cells are
the facial bones and many supportive cells (e.g., pericytes)
of the central nervous system. This shared provenance of
speciﬁc skeletal and brain tissues caught our attention when
we were studying the eﬀect of ethanol on apoptosis of
neural progenitor cells. In fetal alcohol syndrome, a birth
defect caused by maternal consumption of alcoholic bever-
ages during pregnancy, facial malformation, and cognitive
retardation are the most obvious and severe symptoms of
the newborn. Therefore, we hypothesized that neural crest-
derived progenitor cells are very sensitive to ethanol, which
leads to malformation of neural crest-derived tissues in fetal
alcohol syndrome. Our studies showed for the ﬁrst time that
ethanol elevates the expression of PAR-4 and ceramide in
neural crest-derived tissue culture and embryos in vivo [45].
Elevation of PAR-4 leading to enhanced sensitivity toward
ceramide was also found in primary cultured astrocytes
generated from newborn pups that carry a mutation of
presenilin 1 (Psen 1), a gene mutated in familial Alzheimer’s
disease [46]. Taken together, these results strongly suggest
that the simultaneous elevation of PAR-4 and ceramide is
involved in several pathological phenotypes showing tissue
degeneration due to enhanced apoptosis.
About ten years ago, we began to investigate which
cell-signaling pathway is downstream of the ceramide-aPKC
apoptosis complex (CAP-AC), and what distinguishes
the cell-signaling eﬀect of this proapoptotic lipid-protein
complex from that of the ceramide-aPKC-polarity complex
(CAP-PC). Based on experimental evidence obtained
with neuroblastoma cells and ES cell-derived neural
progenitors, our very ﬁrst model suggested that CAP-AC
will reduce activation of Akt/PKB and MAPK/ERK2,
which will lead to activation of Bad and reduced protein
levels of Bcl-2 [36]( Figure 2(b)). Bad and Bcl-2 are two
BH3-only proteins counterregulating apoptosis by either
facilitating or preventing the release of cytochrome c from
mitochondria. In follow-up studies, we found that CAP-
AC also downregulates the transcription factor NF-κB,
which is critical for neural progenitor cell survival [20]
(Figure 2(b)). On the other hand, CAP-PC inactivated GSK-
3β,ad i ﬀerent cell-signaling pathway regulating the function
of β-catenin [21] (Figures 2(b) and 3). Most recently,
we published a model showing that the CAP-AC- and8 Journal of Lipids
PC-induced cell-signaling pathways are at the cross roads of
cell-signaling pathways for apoptosis and cell polarity [22].
Several studies have shown that aPKC phosphorylates
A k ta sw e l la sG S K - 3 β, which coregulates cell survival and
polarity[47–49].IncellswithalowlevelofPAR-4expression
or activity; this pathway will be induced by ceramide. In cells
with high level of PAR-4 expression or activity, however,
this pathway is inhibited, eventually leading to apoptosis.
Therefore, we hypothesize that apoptosis can be understood
as a disorder of cell polarity, which may eliminate cells that
do not polarize or else they would form dysfunctional or
cancerous tissues.
It should be noted that other groups have also inves-
tigated the eﬀect of ceramide on aPKC and Akt [50–
56]. Consistent with our results, one group found that
the ceramide-aPKC interaction leads to inhibition of Akt
[54, 57]. However, this group has attributed the inhibitory
eﬀect to ceramide-induced activation of aPKC. It is possible
that the eﬀect of ceramide on Akt may be modulated by
aPKC-interacting proteins such as Par6 and PAR-4. Recent
evidence in literature suggests that an aPKC-Par6 complex
activates Akt, while an aPKC-PAR-4 complex inactivates this
kinase [47, 58]. Whether aPKC activates or inactivates Akt
may thus critically depend on where and with which other
proteins ceramide-associated aPKC interacts. This compart-
mentalization of ceramide and aPKC will be discussed in the
following and in the last section of this paper.
5. IsIt Time to Deﬁne a SpeciﬁcCeramide
Compartment, the “Sphingosome”?
The previous sections were concerned with the function
of ceramide for individual aspects of cell polarity such as
cell adhesion and migration. Most recently, we have found
evidence that ceramide is involved in another phenomenon
of polarized cells: ciliogenesis [24]. Non-dividing mam-
malian cells, regardless of residing within an epithelium or
migrating, form a primary cilium. This cilium is studded
with growth factor receptors, and it is assumed to act like an
antenna or global positioning system, scanning the environ-
mentforsourcesofgrowthfactors.Whenusingourantibody
against ceramide for immunocytochemistry with ciliated
MDCKcells,wefoundthatatthebasisoftheprimarycilium,
ceramide is highly enriched in a Golgi-derived compartment
[24](Figure 3(b)).Depletionofceramideafterestablishment
of cell adhesion and apicobasal polarity prevented ciliogen-
esis and obliterated the primary cilium. Addition of C16
ceramide or S18 to the medium restored or even enhanced
ciliogenesis. Our study was the ﬁrst evidence that ceramide is
critical for formation or maintenance of the primary cilium.
IthasbeenshowninpreviousstudiesthataPKCiscritical
for ciliogenesis [59, 60]. Therefore, we hypothesized that
the ceramide-aPKC interaction is functionally involved in
this process. Using immunocytochemistry, we found that the
ceramide-enriched compartment at the basis of the primary
cilium engulfed the centriole forming the basal body [24].
We also showed that the ceramide-enriched compartment
was codistributed with the Golgi matrix protein GM130,
a marker for cis Golgi. Most importantly, the ceramide-
enriched compartment was codistributed with aPKC and
Cdc42, indicating that that the core polarity complex
consisting of aPKC-Par6-Cdc42 is associated with ceramide
at the base of the cilium. At this point, we do not know if
ceramide induces, recruits, or sustains this complex. We also
do not know if ceramide is critical for the initial formation
or other processes such as elongation of the primary cilium.
However, it is clear from our studies that the compartmen-
talization of ceramide and therefore, localized formation of
ceramide-associatedproteincomplexesisinstrumentalinthe
regulation of cell polarity and ciliogenesis (Figure 3).
It should be noted that other groups have also found
evidence for the ceramide-dependent compartmentalization
ofintracellularproteins.YusufHannun’sgrouphasdescribed
a juxtanuclear recycling compartment termed “pericentrion”
[61]. Formation of this compartment is induced by activa-
tion of PKCα/β2 with phorbol ester, and it is abolished by
ceramide depletion with fumonisin B1. Although Hannun’s
group did not show ceramide enrichment in this compart-
ment and found a diﬀerent mechanism for the activity of
ceramide (activation of PP2a leading to PKCα/β2-induced
pericentrion sequestration), there are striking similarities to
the apical ceramide-enriched compartment (ACEC) found
in our group. It is also noteworthy that other sphingolipids
have been implicated in the compartmentalization of polar-
ized cells. Pioneering work in Kai Simmon’s and Gerrit
van Meer’s groups demonstrated that glycosphingolipids
and sphingomyelin are asymmetrically transported and
distributed in polarized MDCK cells [62]. Of interest are
also recent studies showing that the gangliosides GM3 and
GM1 are diﬀerentially distributed to microvilli and primary
cilia in polarized cells [63]. Taken together, there is growing
evidence that sphingolipids, and in particular ceramide, may
organize a specialized apical compartment in polarized cells.
We suggest the term “sphingosome” for this compartment to
include ceramide and other sphingolipids in its composition
and generation (Figures 3(b) and 3(c)). We will now
investigate how the sphingosome may be regulated by the
distinct composition of sphingolipids and how it participates
in the regulation of cell polarity and diﬀerentiation.
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